These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 2800014)

  • 1. [Knowledge of, attitudes toward and participation in the new vaccinations against measles, mumps and rubella during the first 2 years].
    Rønne T; Kaaber K; Petersen I
    Ugeskr Laeger; 1989 Sep; 151(38):2418-22. PubMed ID: 2800014
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Changes in measles, mumps and rubella (MMR) immunity until the year of 2002 after the introduction of MMR vaccination].
    Rønne T; Trier H
    Ugeskr Laeger; 1992 Jul; 154(29):2014-8. PubMed ID: 1509567
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Measles, mumps and rubella: control by vaccination.
    van Druten JA; de Boo T; Plantinga AD
    Dev Biol Stand; 1986; 65():53-63. PubMed ID: 3556777
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Age-related seroprevalence of measles, mumps and rubella antibodies in 1996].
    Zäch K; Nicoara C; Germann D; Matter L
    Schweiz Med Wochenschr; 1998 Apr; 128(17):649-57. PubMed ID: 9622837
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Certain problems with limits of immunity against measles, mumps and rubella].
    Magdzik W
    Przegl Epidemiol; 1993; 47(1-2):47-53. PubMed ID: 8351387
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Why do parents hesitate to vaccinate their children against measles, mumps and rubella?
    Alfredsson R; Svensson E; Trollfors B; Borres MP
    Acta Paediatr; 2004 Sep; 93(9):1232-7. PubMed ID: 15384890
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Does a modified vaccination schedule protect better against measles?].
    van 't Spijker C; Rümke HC
    Ned Tijdschr Geneeskd; 1994 Nov; 138(48):2400-5. PubMed ID: 7990988
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A randomized comparative trial in order to assess the reactogenicity and immunogenicity of a new measles mumps rubella (MMR) vaccine when given as a first dose at 12-24 months of age.
    Gatchalian S; Cordero-Yap L; Lu-Fong M; Soriano R; Ludan A; Chitour K; Bock HL
    Southeast Asian J Trop Med Public Health; 1999 Sep; 30(3):511-7. PubMed ID: 10774661
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Evaluation of measles, mumps and rubella vaccine coverage in 3 year old children in twelve French counties. Time-trends and related factors].
    Rotily M; Guagliardo V; Fontaine D; Garros B; Mayer C; Arrighi J; Woronoff AS; Ledesert B; Lepec R; Chabaud F; Janvrin MP; Baudier F
    Rev Epidemiol Sante Publique; 2001 Sep; 49(4):331-41. PubMed ID: 11567200
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Illness after measles-mumps-rubella vaccination.
    Freeman TR; Stewart MA; Turner L
    CMAJ; 1993 Dec; 149(11):1669-74. PubMed ID: 8242506
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Attitudes and knowledge among parents who do not want their children to be vaccinated against measles, mumps and rubella (MFR-vaccination)].
    Haurum J; Johansen M
    Ugeskr Laeger; 1991 Mar; 153(10):705-9. PubMed ID: 2008713
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Attitude of parents to MMR vaccination].
    Petersen LK
    Ugeskr Laeger; 1991 May; 153(22):1599-600. PubMed ID: 2058024
    [No Abstract]   [Full Text] [Related]  

  • 13. [Vaccination status and implementation of recommendations for vaccination with special reference to measles-mumps-rubella vaccination. 1995 program for school entrance].
    Ziemer B; Blank K; Hennig R
    Gesundheitswesen; 1998 May; 60(5):297-300. PubMed ID: 9676011
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vaccination with a combined vaccine against measles, mumps and rubella aiming at elimination of the three diseases.
    Böttiger M; Christenson B; Strandell A; Romanus V
    Dev Biol Stand; 1986; 65():37-43. PubMed ID: 3556776
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Measles, mumps and rubella: vaccination rate and seroprevalence in 8th grade students of 8 different sites in Switzerland 1995/96].
    Stohrer-Draxl P; Amstad H; Grize L; Gassner M; Takken-Sahli K; Bourquin C; Braun-Fahrländer C
    Praxis (Bern 1994); 1999 Jun; 88(24):1069-77. PubMed ID: 10420798
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Reactions after MMR vaccination].
    Kaaber K; Samuelsson IS; Larsen SO
    Ugeskr Laeger; 1990 Jun; 152(23):1672-6. PubMed ID: 2363211
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Experience with preventive measles, mumps and rubella vaccination in unified Germany].
    Gerike E; Tischer A
    Gesundheitswesen; 1993 Jan; 55(1):38-9. PubMed ID: 8435543
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MMR immunisation coverage in Christchurch. Christchurch Immunisation Coordination Committee.
    Ford RP; Bell DW; Slade B; McCormack SP
    N Z Med J; 1998 Aug; 111(1071):301. PubMed ID: 9760956
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Seroepidemiological study of measles after the 1992 nationwide MMR revaccination program in Taiwan.
    Chiu HH; Lee CY; Chih TW; Lee PI; Chang LY; Lin YJ; Hsu CM; Huang LM
    J Med Virol; 1997 Jan; 51(1):32-5. PubMed ID: 8986946
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence of IgG-antibodies to mumps and measles virus in non-vaccinated children.
    Glikmann G; Petersen I; Mordhorst CH
    Dan Med Bull; 1988 Apr; 35(2):185-7. PubMed ID: 3359817
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.